MEDIROM Healthcare TechnologiesvsTesla

MRM and TSLA stock compared: price, dividend, valuation and results, from SEC filings.

MEDIROM Healthcare Technologies (MRM) has a market value of $1.8M and Tesla (TSLA) $1.37T. Over the last year, with dividends, MRM moved -88.9% and TSLA -14.4%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRM$1.8M

    TSLA$1.37T

    TSLA is 752,122 times MRM

  • Revenue, 12 months

    MRM$50M

    TSLA$104B

    TSLA is 2,092 times MRM

  • Net income, 12 months

    MRM-$23M

    TSLA$3.2B

  • Operating margin

    MRM-43.7%

    TSLA3.4%

    47.1 points apart

  • ROIC

    MRM–

    TSLA2.9%

  • P/E

    MRM–

    TSLA424.8

  • Dividend yield

    MRM0.0%

    TSLA0.0%

    About the same

  • 5-year return

    MRM-97.0%

    TSLA-8.8%

    88.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRM-97.0%

TSLA-8.8%

05010020222023202420252026
Returns by period
PeriodMRMWith dividendsTSLAWith dividends
1 year since November 19, 2025-88.9%Price -88.9%-14.4%Price -14.4%
3 years since November 20, 2023-95.3%-63.9% a yearPrice -95.3%+46.8%+13.6% a yearPrice +46.8%
5 years since November 19, 2021-97.0%-50.4% a yearPrice -97.0%-8.8%-1.8% a yearPrice -8.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRMMEDIROM Healthcare TechnologiesTSLATesla

Valuation

MRMTSLA
Valuation
Price$0.23$345.82
Market value$1.8M$1.37T
Enterprise value (EV)–$1.33T
P/E–424.8
P/E, 5-year median21.8–
P/B–15.3
EV/EBIT–384.0
Free cash flow yield–0.2%

Results and growth

MRMTSLA
Results and growth
Revenue, 12 months$50M$104B
Net income, 12 months-$23M$3.2B
Free cash flow, 12 months-$7.4M$3.3B
Earnings per share, 12 months-$2.93$0.91
Revenue growth, year on year-6.5%-2.9%
Revenue growth a year, past+18.4%over 5 years+24.6%over 5 years
EPS growth a year, past–+38.8%over 5 years

Margins and returns on capital

MRMTSLA
Margins and returns on capital
Gross margin–19.3%
Operating margin-43.7%3.4%
Net margin-46.8%3.1%
ROIC–2.9%
ROE–3.8%

Balance sheet

MRMTSLA
Balance sheet
Cash$625.9K$45.4B
Total debt–$16.4B
Net debt / EBITDA–-4.2
Interest cover–10.0×

Dividends and buybacks

MRMTSLA
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield––
Shareholder yield––

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRM or TSLA

Didn't find what you were looking for?

Ask us
Which is bigger, MEDIROM Healthcare Technologies or Tesla?

By market value, Tesla ($1.37T) is about 752,121.9 times MEDIROM Healthcare Technologies ($1.8M), at today's prices.

How did MRM and TSLA stock do over the last 5 years?

Since November 19, 2021, MRM's price moved -97.0% and TSLA's -8.8%. With dividends: MRM -97.0% (-50.4% a year), TSLA -8.8% (-1.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRM or TSLA?

Neither paid a dividend over the last twelve months: MEDIROM Healthcare Technologies and Tesla return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, MEDIROM Healthcare Technologies or Tesla?

Over the last twelve months, the net margin was -46.8% for MEDIROM Healthcare Technologies and 3.1% for Tesla, and the operating margin -43.7% and 3.4%. Revenue was $50M and $104B.

Which is the better investment, MEDIROM Healthcare Technologies or Tesla?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.